Effect of anti-Ebola virus monoclonal antibodies on endogenous antibody production in survivors of Ebola virus disease in the Democratic Republic of the Congo: an observational cohort study.

Background: The use of specific anti-Ebola virus therapy, especially monoclonal antibodies, has improved survival in patients with Ebola virus disease. We aimed to assess the effect of monoclonal antibodies on anti-Ebola virus antibody responses in survivors of the 2018-20 Ebola outbreak in the Democratic Republic of the Congo.

Methods: In this observational prospective cohort study, participants were enrolled at three Ebola survivor clinics in Beni, Mangina, and Butembo (Democratic Republic of the Congo).

[Iron deficency and anemia among donors in Kinshassa].

Introduction: In the Democratic Republic of Congo (DRC), the practice of blood transfusion is common with more than two hundred thousand one million blood donation per year has been made between 2007 and 2011. However, no report on iron deficiency and iron deficiency anemia as a result of a donation blood in DS is available in this country. This study aimed to estimate the extend of iron deficiency, anemia and iron deficiency anemia in volunteer blood donors (DS) in the National Blood Transfusion Center (CNTS) in Kinshasa, DRC.